Satoshi Yotsuyanagi Selected Research

Cholinergic Agents (Cholinergics)

1/2002

Overactive bladder--experimental aspects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Satoshi Yotsuyanagi Research Topics

Disease

4	Cerebral Infarction 07/2005 - 01/2002
2	Carcinoma (Carcinomatosis) 12/2021 - 03/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2012
1	Neoplasm Metastasis (Metastasis) 12/2012
1	Infarction (Infarctions) 07/2005
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2003
1	Alzheimer Disease (Alzheimer's Disease) 01/2002

Drug/Important Bio-Agent (IBA)

2	pembrolizumabIBA 12/2021 - 03/2021
2	Messenger RNA (mRNA)IBA 05/2003 - 01/2002
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Interferon-alpha (Interferon Alfa)IBA 12/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2005
1	Protein Isoforms (Isoforms)IBA 07/2005
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 07/2005
1	RNA (Ribonucleic Acid)IBA 05/2003
1	Halothane (Fluothane)FDA Link 05/2003
1	Dactinomycin (Actinomycin)FDA LinkGeneric 05/2003
1	Nucleic Acid Synthesis InhibitorsIBA 05/2003
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2003
1	Cholinergic Agents (Cholinergics)IBA 01/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2002
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2002
1	N-Methylaspartate (NMDA)IBA 01/2002

Therapy/Procedure

2	Therapeutics 12/2021 - 03/2021
1	Anesthesia 05/2003